首页>
外国专利>
Biomarkers for syncope diagnosis, prognosis, assessment, and treatment stratification
Biomarkers for syncope diagnosis, prognosis, assessment, and treatment stratification
展开▼
机译:用于晕厥诊断,预后,评估和治疗分层的生物标志物
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to a method for the diagnosis and/or prognosis and/or assessment and/or therapy stratification of syncope in a patient the method comprising: determining the level of at least one biomarker selected from the group consisting of proADM, proANP, proBNP, proAVP, proET-1 and PCT or a fragment of at least 12 amino acids thereof, in a sample of a bodily fluid of said patient, correlating said level of at least one biomarker or fragments thereof with the diagnosis and/or prognosis and/or assessment and/or therapy stratification of syncope.
展开▼